⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LXRX News
Lexicon Pharmaceuticals, Inc.
Lexar and Leica Present Threads of Time: A Journey Through Silk and Lens at Leica Gallery Amsterdam
prnewswire.com
LXRX
Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences
globenewswire.com
LXRX
Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure
globenewswire.com
LXRX
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851
globenewswire.com
LXRX
Form 8-K
sec.gov
LXRX
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
globenewswire.com
LXRX
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
globenewswire.com
LXRX
Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
globenewswire.com
LXRX
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
prnewswire.com
CYTK
NVO
BCDA
AZN
BMY
LLY
MESO
ASMB
LXRX
VTRS
AMGN
IRWD
NVS
MRK
Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)
globenewswire.com
LXRX